Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration
Intravenously administered for the treatment of rectum cancer, irinotecan produces severe side effects due to very high plasma concentrations. A novel irinotecan-encapsulated double reverse thermosensitive nanocarrier system (DRTN) for rectal administration was developed as an alternative. The DRTN...
Shranjeno v:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Knjiga |
Izdano: |
Taylor & Francis Group,
2017-01-01T00:00:00Z.
|
Teme: | |
Online dostop: | Connect to this object online. |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Kopija 1 | Prosto |